Page last updated: 2024-08-23

2,5,2',5'-tetrachlorobiphenyl and Hepatocellular Carcinoma

2,5,2',5'-tetrachlorobiphenyl has been researched along with Hepatocellular Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aarts, JM; Brouwer, A; Cox, MA; de Haan, LH; Denison, MS; Garrison, PM; Schalk, MA; Tullis, K1

Other Studies

1 other study(ies) available for 2,5,2',5'-tetrachlorobiphenyl and Hepatocellular Carcinoma

ArticleYear
Species-specific antagonism of Ah receptor action by 2,2',5,5'-tetrachloro- and 2,2',3,3'4,4'-hexachlorobiphenyl.
    European journal of pharmacology, 1995, Dec-07, Volume: 293, Issue:4

    Topics: Animals; Base Sequence; Carcinoma, Hepatocellular; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Enzyme Induction; Guinea Pigs; Humans; Luciferases; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Oxidoreductases; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Rats; Rats, Sprague-Dawley; Receptors, Aryl Hydrocarbon; Tumor Cells, Cultured

1995